North America

Baird’s Duksin: 40 Act funds make up 15-20% of secondaries market demand

While ’40 Act funds haven’t yet moved market pricing in GP-led deals, these evergreen funds are ‘certainly are participating and creating syndicate demand’, Baird’s GP solutions group co-head Jeremy Duksin tells Secondaries Investor.

Goldman Sachs leads on Tailwater single-asset deal

The deal is one of the rarer energy assets to make use of secondaries as a way to extend holds and deliver liquidity to limited partners in an older fund.

CPP Investments names new head of secondaries

The $524.4bn investor has been actively using the secondaries market as a portfolio management tool, as well as for buyside opportunities.

Vermont works to get dollars in the ground in secondaries

While some LP consultants argue it is difficult for LPs to gain access to top-decile secondaries funds, Vermont CIO Eric Henry argues that mentality can also be applied to the primary market.

Partners Capital: LPs need to watch out for co-investment ‘style drift’ towards secondaries

GPs need to be transparent with LPs about the impacts of having GP-led deals in co-investment funds, Partners Capital’s head of co-investments Adam Spence says.

Dawson backs $2bn+ pref equity deal with Thrivent

The deal is the largest Dawson has completed and comes as the firm continues to raise its largest flagship vehicle to date.

Taiwan Life Insurance commits to Ardian secondaries fund

Taiwan Life Insurance commits $50m to Ardian’s infrastructure secondaries fund.

Unpacking the early rise of GP stake secondaries

In this podcast, two industry veterans discuss the different types of GP stake secondaries transactions, the motivations driving market participants to pursue such deals, and the outlook for this emerging segment of the secondaries market.

HarbourVest targets $20bn for latest secondaries flagship

The fund will target an even split of LP- and GP-leds, primarily in North America.

Prized assets trump solution-focused CV deals as lead buyer bottleneck persists

While many secondaries investors are willing to join as syndicate participants, few are willing to take on the ‘onerous’ task of a lead investor role in CVs, panellists said at the Fund Finance Association European Symposium held in London.